Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
64
NCT02709343
Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction
Phase: Phase 2
Role: Collaborator
Start: Apr 21, 2017
Completion: Oct 25, 2023